The morning of the innovation analyzed the economic value of biotechnology in the pharmaceutical and agri-food industry
July 2, 2007
The content of the mornings of innovation gave to learn about the latest technologies that currently work technological institutes, research groups and Catalan companies in a particular sector and its practical application in the industrial fabric of the country to increase their competitiveness. The introduction of advances provided by the research shows the way to provide a better service, quality and price, and strengthen the competitive advantages of our businesses in a global market.
- The role of clusters in the biotechnology environment. Montserrat Vendrell, Director of the Bioregion of Catalonia (BIOCAT)
- The technology transfer in biotechnology. Pere Condom, director of the Science Park and technological-UdG
- The financing of biotechnology companies: peculiarities, challenges and trends. Josep M. Echarri, Chief Financial Officer of Oryzon Genomics
- Impact of biotechnology in the pharmaceutical industry. Olga Fidalgo, Corporate Director of business development and licensing of the Group Ferrer, S.A.
- New genomic technologies. An opportunity for the agri-food sector. Pere Puigdomènech, director of the Center for research in Agrogenómica-CSIC-IRTA_UAB.